Pharmaceuticals, Biotechnology and Life Sciences
Sanofi said Friday that Libtayo (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time.
Mylan said on Friday that the U.S. Patent and Trademark Appeal Board (PTAB) has ruled in favor of Mylan in inter partes review (IPR) proceedings finding all challenged claims of Sanofi’s Lantus® SoloSTAR® device patents, U.S. Patent Nos. 8,603,044, 8,992,486, and 9,526,844 unpatentable.
Validation of Type II Variation will allow Takeda to commence launches in Europe later this year The pre-filled syringe presentation…
Data from Phase III EXPAND trial, continue to build on existing clinical evidence that Mayzent has significant impact on reducing the risk of disease progression, including physical disability and cognitive decline for patients with SPMS.
OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) today announces that on May 28, the European Commission (the “EC”)…
Analyses from KEYTRUDA Plus LENVIMA Trials to be Presented at 2020 ASCO Annual Meeting KENILWORTH, N.J. & WOODCLIFF LAKE, N.J.–(BUSINESS…
A pharmaceutical outsourcing partner, the Wasdell Group (Wasdell), has been granted an Investigational Medicinal Product (IMP) licence by the Health Products Regulatory Authority (HPRA) at its Dundalk, Ireland facility.
RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy for treating all stages of cancer, today announced a clinical collaboration with Merck.
Seal of quality for outstanding corporate management Analysis of the areas of strategy, innovation, corporate culture and finance Comprehensive three-stage…
Collaboration will test pre-clinical efficacy and safety of vaccine pipeline including COVID-19 and other coronaviruses PHILADELPHIA & FAIRFAX, Va.–(BUSINESS WIRE)–Chimeron…